Primary Outcome
uveitis
UVEITIS
Symptomatic uveitis worsening occurred in 51 patients (19.5%) recommended for early COVID-19 vaccination and in 34 (12.1%) recommended for deferred COVID-19 vaccination (between-group difference, 7.4% [95% CI, 1.2%-13.6%]). In the intention-to-treat analysis, the time to symptomatic uveitis worsening was shorter in the early vaccination group than in the deferred vaccination group (HR, 1.68 [95% CI, 1.09-2.59]; 